Noticias de ILMN_US

Noticias del mercado

Últimas noticias sobre ILMN_US — 47 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ILMN_US ✕ 47 resultados
02/04/2026 ILMN_US — Stock Titan
Illumina (ILMN) director Scott Ullem takes 2026 retainer as 190 ILMN shares
02/04/2026 ILMN_US — Stock Titan
Illumina (NASDAQ: ILMN) nominates David P. King as three directors retire
02/04/2026 ILMN_US — Stock Titan
Illumina (NASDAQ: ILMN) director paid in stock, linked to Corvex funds
02/04/2026 ILMN_US — MarketScreener
Illumina, Inc. Announces Board Retirements, Effective May 21, 2026
02/04/2026 ILMN_US — PR Newswire
Illumina Announces Changes to Board of Directors
31/03/2026 ILMN_US — MarketWatch
Illumina Inc. stock rises Tuesday, still underperforms market
18/03/2026 ILMN_US — PR Newswire
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
18/03/2026 ILMN_US — Finansavisen ES ← EN
Illumina y Labcorp amplían su colaboración para ampliar el acceso a pruebas oncológicas de precisión
16/03/2026 ILMN_US — PR Newswire
Illumina advances preventive genomics through strategic consortium with Veritas Genetics
09/03/2026 ILMN_US — DirectorsTalk Interviews
Illumina, Inc. (ILMN) Stock Analysis: Evaluating Its 9.17% Potential Upside and Market Position
05/03/2026 ILMN_US — Insider Monkey ES ← EN
Illumina (ILMN) obtiene resultados mejores de lo esperado
05/03/2026 ILMN_US — Stock Traders Daily
How Illumina Inc. (ILMN) Affects Rotational Strategy Timing
02/03/2026 ILMN_US — GuruFocus
Illumina Inc (ILMN) Trading Down 2.84% on Mar 2
27/02/2026 ILMN_US — PR Newswire
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
25/02/2026 ILMN_US — PR Newswire
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
24/02/2026 ILMN_US — PR Newswire
Illumina launches TruPath Genome, setting a new standard in genomic insight
23/02/2026 ILMN_US — PR Newswire
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility
23/02/2026 ILMN_US — DirectorsTalk Interviews ES ← EN
Análisis de acciones de Illumina, Inc. (ILMN): explorando un potencial de mejora del 15,62% en el sector genómico
10/02/2026 ILMN_US — MarketWatch ES ← EN
Las acciones de Illumina Inc. tuvieron un rendimiento inferior el martes en comparación con sus competidores a pesar de las ganancias diarias
06/02/2026 ILMN_US — Insider Monkey
Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript

Página 2 de 3

keyboard_arrow_up